secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2025-10-29T23:59:59+00:00
Accession:  0001104659-25-103774
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva Biologics files $2.9M at-the-market equity offering through A.G.P.
--------------------------------------------------------------------------

- Company filed a prospectus supplement for up to $2,894,225 of common stock in an ATM offering.
- Sales agent is A.G.P./Alliance Global Partners; commission rate up to 3.0% of gross sales price.
- Shares offered under existing effective S-3 registration statement (File No. 333-279077).
- No arrangement for funds to be received in escrow; sales at market prices via commercial efforts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465925103774/0001104659-25-103774-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465925103774/tm2529686d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-103774

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer